1. Godman B, Oortwijn W, De Waure C, et al. Links between pharmaceutical R&D models and access to affordable medicines. European Union, PE 587.321 EN. IP/A/ENVI/2015-06. 2016. Available from: http://www.europarl.europa.eu/thinktank/en/document.html?reference=IPOL_STU(2016)587321. [Accessed December 2, 2016].
2. International Network of Agencies for Health Technology Assessment; Health Technology Assessment international. HTA glossary. Available from: http://htaglossary.net/health+technology+assessment+%28HTA%29. [Accessed November 15, 2016].
3. Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makers;Tanios;Int J Technol Assess Health Care,2013
4. Facey K. Improving the effectiveness and efficiency of evidence production for HTA in the light of current trends in drug and device development, health system funding, regulation and HTA. Background Paper Policy Forum. 2015. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697336/pdf/S0266462315000355a.pdf. [Accessed April 14, 2017].
5. Managing Scarcity: Priority Setting and Rationing in the National Health Service;Klein,1996